市場調査レポート
商品コード
1575027

インシリコ創薬市場:製品タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年予測

In-Silico Drug Discovery Market, By Product, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 260 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.56円
インシリコ創薬市場:製品タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

インシリコ創薬市場規模は2023年に29億8,032万米ドルとなり、2024年から2032年にかけてCAGR 10.30%で拡大

インシリコ創薬市場- 市場力学

計算能力とAIの進歩、構造生物学技術の出現が市場需要を促進する見込み

ハイパフォーマンス・コンピューティング(HPC)やクラウドベースのプラットフォームが利用可能になったことで、より複雑なシミュレーションや大規模なデータ処理が可能になった。人工知能(AI)と機械学習(ML)の統合により、創薬の予測精度と効率がさらに向上し、インシリコ創薬市場の成長を後押ししています。AIとビッグデータ解析は、大規模な生物学的データセットの解析、新薬ターゲットの同定、薬物相互作用と毒性プロファイルの予測に利用され、より正確で個別化された医薬品開発を可能にしています。

構造生物学、ゲノミクス、プロテオミクス、メタボロミクスの進歩により、生体システムに関する膨大な量のデータが生成されています。インシリコ創薬ツールは、このデータを利用して新規創薬ターゲットを同定し、疾患メカニズムを解明します。さらに、製薬企業や学術機関による研究開発費、特に計算生物学やバイオインフォマティクスの研究開発費が増加したことで、創薬・薬剤開発にインシリコツールの導入が進んでいます。多くの製薬企業がインシリコ創薬プロセスを専門企業にアウトソーシングしており、市場の成長をもたらしています。製薬会社、学術機関、ハイテク企業間のコラボレーションも、イノベーションと市場拡大を加速させています。

インシリコ創薬市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間(2024-2032年)に約10.30%のCAGRで毎年成長すると推定されます。

製品タイプ別では、インターネット普及率の上昇とIoTソリューションの採用により、サービスとしてのソフトウェアセグメントが2023年に最大市場シェアを示すと予測されました。

疾患タイプ別では、がん疾患が増加していることから、2023年の疾患タイプ別市場シェアはがん疾患がトップでした。

エンドユーザー別では、バイオ製薬企業による創薬への投資が増加していることから、2023年にはバイオ製薬企業セグメントが主要エンドユーザセグメントとなった。

地域別では、北米が2023年の主要収益企業でした。これは、トップ製薬企業の存在と政府の有利な政策によるものです。

インシリコ創薬市場-セグメンテーション分析:

世界のインシリコ創薬市場は、製品タイプ、疾患タイプ、エンドユーザー、地域によって区分されます。

製品タイプは、サービスとしてのソフトウェアとサービスとしてのコンサルティングの2つに分類されます。サービスとしてのソフトウェア分野が市場を独占しています。医療ツールにおけるビッグデータとAIの採用が増加していることが、このセグメントの成長に寄与しています。

市場は、疾患タイプに基づいて、がん、神経疾患、感染症、代謝疾患、心血管疾患、その他の6つに分類されます。オンコロジー分野は市場を独占しています。インドNIHによると、がん患者の増加は2025年までに12.5%増加すると予測されています。

市場はエンドユーザー別にバイオ製薬企業、CRO、学術研究、その他の4つに分類されます。バイオ製薬企業セグメントが市場を独占しており、予測期間中も高い優位性を維持すると予想されます。バイオ医薬品企業は医薬品開発を効率化し、研究開発に投資することで市場の成長を支えています。

インシリコ創薬市場-地理的洞察

地域的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米、特に米国がインシリコ創薬市場で最大のシェアを占めています。AI、機械学習、ハイパフォーマンス・コンピューティング(HPC)などの先端技術が創薬に採用されています。欧州は第2位の市場で、GSK、アストラゼネカなどの企業を擁するドイツ、英国、フランスなどの国々があります。これらの企業は研究開発(R&D)への高額投資を重視しています。

インシリコ創薬市場-競合情勢:

インシリコ創薬市場は競争が激しく、予測精度の向上、コスト削減、医薬品開発プロセスのスピードアップのため、AIや機械学習を取り入れる企業が増えています。Insilico Medicine社やAtomwise社などの企業は、薬剤ターゲットの同定、化合物の最適化、ADMET(吸収・分布・代謝・排泄・毒性)特性の予測を改善するため、AIプラットフォームを継続的に強化しています。また、市場企業は、創薬とバイオインフォマティクスへの投資が増加しているアジア太平洋のような新興市場に進出しています。

2023年、BenevolentAIは慢性腎臓病や特発性肺線維症を含む様々な治療領域にわたる新規ターゲットの発見と検証のため、アストラゼネカと戦略的提携を結びました。

2023年9月、データサイエンス主導の創薬企業であるRelated Sciences社は、Charles River Laboratories International, Inc.と提携し、多数の未薬物化ターゲットにLogicaTMを展開しました。

目次

第1章 インシリコ創薬市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 インシリコ創薬の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 インシリコ創薬産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 インシリコ創薬市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 インシリコ創薬市場情勢

  • インシリコ創薬市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 インシリコ創薬市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • サービスとしてのソフトウェア
    • サービスとしてのコンサルティング

第8章 インシリコ創薬市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • 腫瘍学
    • 神経疾患
    • 感染症
    • 代謝障害
    • 心血管疾患
    • その他

第9章 インシリコ創薬市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • バイオ医薬品企業
    • CRO
    • 学術調査
    • その他

第10章 インシリコ創薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- インシリコ創薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Schrodinger Inc.
    • Simulations Plus Inc.
    • Charles River Laboratories
    • Certara Inc.
    • Evotec SE
    • Insilico Medicine
    • Atomwise
    • BenevolentAI
    • Exscientia
    • Dassault Systemes(BIOVIA)
    • GNS Healthcare
    • Genedata AG
    • Collaborative Drug Discovery(CDD)
    • OpenEye Scientific Software
    • ChemAxon
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4020

REPORT HIGHLIGHT

In-Silico Drug Discovery Market size was valued at USD 2,980.32 Million in 2023, expanding at a CAGR of 10.30% from 2024 to 2032.

In-silico drug discovery utilizes computational methods and simulations to identify, design, and optimize potential drug candidates. This approach leverages computer-based tools to model biological systems, predict drug interactions, and explore chemical space, which significantly speeds up the drug discovery process and reduces costs compared to traditional experimental methods.

In-Silico Drug Discovery Market- Market Dynamics

Advancement in computational power & AI and emergence of structural biology, technologies is expected to propel market demand

The increased availability of high-performance computing (HPC) and cloud-based platforms has enabled more complex simulations and large-scale data processing. The integration of artificial intelligence (AI) and machine learning (ML) further enhances predictive accuracy and efficiency in drug discovery, thereby boosting the in-silico drug discovery market growth. AI and big data analytics are being used to analyze large biological datasets, identify new drug targets, and predict drug interactions and toxicity profiles, enabling more precise and personalized drug development.

Advances in structural biology, genomics, proteomics, and metabolomics have generated vast amounts of data on biological systems. In-silico drug discovery tools utilize this data to identify novel drug targets and understand disease mechanisms. In addition, increased R&D spending by pharmaceutical companies and academic institutions, especially in computational biology and bioinformatics, has led to greater adoption of in-silico tools for drug discovery and development. Many pharmaceutical companies are outsourcing in-silico drug discovery processes to specialized firms, leading to market growth. Collaborations between pharma companies, academic institutions, and tech firms are also accelerating innovation and market expansion.

In-Silico Drug Discovery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2024-2032)

Based on Product segmentation, the software-as-a-service segment was predicted to show maximum market share in the year 2023, owing to rising internet penetration & adoption of IoT solution.

Based on Disease Type segmentation, oncology segment was the leading Disease Type segment in 2023, due to the growing prevalence of oncological disorders.

Based on End User segmentation, biopharmaceutical companies' segment was the leading End User segment in 2023, due to the rising number investment by biopharma companies in drug discoveries.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of top pharma companies & favorable government policies.

In-Silico Drug Discovery Market- Segmentation Analysis:

Global In-Silico Drug Discovery Market is segmented on the basis of Product, Disease Type, End User, and Region.

The market is divided into two categories based on Product: software-as-a-service and consultancy-as-a-service. The software-as-a-service segment dominates the market. The increasing adoption of big data and AI in medical tools is contributing to segment growth.

The market is divided into six categories based on Disease Type: oncology, neurological disorders, infectious disorders, metabolic disorders, cardiovascular diseases, and others. The oncology segment dominates the market. The increasing number of cancer cases, according to NIH, India, cancer cases are expected to rise by 12.5% by 2025.

The market is divided into four categories based on End User: biopharmaceutical companies, CROs, academic research, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Biopharmaceutical companies streamline their drug development & investing in research supporting market growth.

In-Silico Drug Discovery Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, especially the United States, holds the largest share in the in-silico drug discovery market. Adoption of advanced technologies like AI, machine learning, and high-performance computing (HPC) in drug discovery. Europe is the second-largest market, with countries like Germany, the UK, and France with companies like GSK, AstraZeneca, etc. These companies are emphasizing on high investment in research and development (R&D).

In-Silico Drug Discovery Market- Competitive Landscape:

The In-Silico Drug Discovery market is highly competitive, Companies are increasingly incorporating AI and machine learning to enhance prediction accuracy, reduce costs, and speed up the drug development process. Companies such as Insilico Medicine and Atomwise are continually enhancing their AI platforms to improve drug target identification, compound optimization, and prediction of ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties. Also, market players are expanding into emerging markets like Asia-Pacific, where investments in drug discovery and bioinformatics are increasing.

In 2023, BenevolentAI entered a strategic collaboration with AstraZeneca to discover and validate novel targets across various therapeutic areas, including chronic kidney disease and idiopathic pulmonary fibrosis.

In September 2023, Related Sciences, a data science-driven drug discovery company collaborated with Charles River Laboratories International, Inc. to deploy LogicaTM for numerously undrugged targets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-SILICO DRUG DISCOVERY MARKET KEY PLAYERS

  • Schrodinger Inc.
  • Simulations Plus Inc.
  • Charles River Laboratories
  • Certara Inc.
  • Evotec SE
  • Insilico Medicine
  • Atomwise
  • BenevolentAI
  • Exscientia
  • Dassault Systemes (BIOVIA)
  • GNS Healthcare
  • Genedata AG
  • Collaborative Drug Discovery (CDD)
  • OpenEye Scientific Software
  • ChemAxon
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Software-as-a-service
  • Consultancy-as-a-service

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Neurological disorders
  • Infectious disorders
  • Metabolic disorders
  • Cardiovascular diseases
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical companies
  • CROs
  • Academic research
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-Silico Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-Silico Drug Discovery Market Snippet by Product
    • 2.1.2. In-Silico Drug Discovery Market Snippet by Disease Type
    • 2.1.3. In-Silico Drug Discovery Market Snippet by End User
    • 2.1.4. In-Silico Drug Discovery Market Snippet by Country
    • 2.1.5. In-Silico Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. In-Silico Drug Discovery Key Market Trends

  • 3.1. In-Silico Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-Silico Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-Silico Drug Discovery Market Opportunities
  • 3.4. In-Silico Drug Discovery Market Future Trends

4. In-Silico Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-Silico Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-Silico Drug Discovery Market Landscape

  • 6.1. In-Silico Drug Discovery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-Silico Drug Discovery Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Software-as-a-service
    • 7.1.3. Consultancy-as-a-service

8. In-Silico Drug Discovery Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurological disorders
    • 8.1.4. Infectious disorders
    • 8.1.5. Metabolic disorders
    • 8.1.6. Cardiovascular diseases
    • 8.1.7. Others

9. In-Silico Drug Discovery Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical companies
    • 9.1.3. CROs
    • 9.1.4. Academic research
    • 9.1.5. Others

10. In-Silico Drug Discovery Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-Silico Drug Discovery Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-Silico Drug Discovery Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-Silico Drug Discovery Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-Silico Drug Discovery Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-Silico Drug Discovery Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-Silico Drug Discovery Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Schrodinger Inc.
    • 11.2.2. Simulations Plus Inc.
    • 11.2.3. Charles River Laboratories
    • 11.2.4. Certara Inc.
    • 11.2.5. Evotec SE
    • 11.2.6. Insilico Medicine
    • 11.2.7. Atomwise
    • 11.2.8. BenevolentAI
    • 11.2.9. Exscientia
    • 11.2.10. Dassault Systemes (BIOVIA)
    • 11.2.11. GNS Healthcare
    • 11.2.12. Genedata AG
    • 11.2.13. Collaborative Drug Discovery (CDD)
    • 11.2.14. OpenEye Scientific Software
    • 11.2.15. ChemAxon
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us